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Background: Cystic fibrosis (CF) is considered to be rare among individuals from the Indian subcontinent.
Furthermore, affected individuals are reported to experience a more severe clinical course.
Aims: It was hypothesised that CF is under diagnosed in people of South Asian origin and therefore the
prevalence may be higher than previously estimated.
Methods: The prevalence of CF in the South Asian and in the general population living in the same
geographic region (Metropolitan Toronto) were compared between 1996 and 2001. Population data
were obtained from the Canadian census survey. CF phenotype and genotype data were obtained from
the Toronto CF database.
Results: Among 381 patients with CF, 15 were of South Asian descent. The age related prevalence of CF
among the South Asian and general populations was: 0–14 years, 1:9200 versus 1:6600; 15–24 years,
1:13 200 versus 1:7600; older than 25 years, 1:56 600 versus 1:12 400. Age at diagnosis, duration
and severity of symptoms at diagnosis, current nutritional status, and FEV1 were similar in the two groups.
While not significant, FEV1 tended to be lower (48% versus 57% predicted) among adult South Asians,
compared to the general CF population. Also, the percentage with pancreatic sufficiency was higher (27%
versus 16%) and the frequency of DF508 allele was lower (50% versus 65.1%).
Conclusions: These data suggest that the prevalence and natural history of CF in South Asians is similar to
that among individuals of European origin. The relatively lower prevalence among older South Asians
may reflect an improving recognition of CF in this ethnic subgroup.
W
hile cystic fibrosis (CF) is the most common fatal
inherited disease in the European Caucasian popu-
lation, it is considered to be rare among individuals
from other ethnic groups, including those from the Indian
subcontinent. Several reports have described CF in the Indian
subcontinent population,1–7 as well as in individuals from the
same ethnic origin, who immigrated to other countries.8–12
These reports estimate the incidence of CF in this ethnic
group to be between 1:10 000 and 1:40 750.8 11
DF508, the most common genetic mutation among CF
patients of European origin and in the global CF population,
appears to be less common in CF patients of South Asian
origin.6 7 9–12 Also, patients with CF from the Indian sub-
continent have been reported to experience a more severe
clinical course than age matched Caucasian children.10
However, it is unclear whether the natural course of the
disease is more severe, or whether other factors including
diagnostic, social, and environmental factors adversely affect
the clinical course or its reporting.
Since South Asians are considered to be partially of
Caucasian origin, we hypothesised that the prevalence of
CF in this ethnic group is higher than previously estimated.
To test this hypothesis, the age related prevalence of CF in a
South Asian population was compared with the general
population living in the same geographic region. We also
compared the genotypes, presentation at diagnosis, and
natural history of the disease in the two groups.
PATIENTS AND METHODS
Patients
Patients with CF living in Toronto and attending one of two
specialised CF clinics (paediatric and adult) in the period
1996–2001 were selected for the study. The diagnosis of CF
was based on sweat chloride levels (.60 mEq/l) and/or two
identified CF mutations, as well as characteristic symptoms
of CF. For patients with equivocal results, nasal potential
difference testing was used to confirm the diagnosis of CF.
We used the most recent Statistics Canada census (1996)
estimates of the general and the South Asian population in
the Metropolitan Toronto area.13 Statistics Canada census
(1996) defines all individuals of Indian, Pakistani, Punjabi,
and Sri Lankan origin as South Asian. CF patients of South
Asian origin were identified using our CF database, hospital
records, and by direct questioning. The prevalence of CF in
the general and South Asian population was calculated using
our database and the Statistics Canada 1996 census data.
We utilised the Metropolitan Toronto area, because the
vast majority of South Asians residing in the Province of
Ontario live in this area. Furthermore, all South Asian CF
patients attending the Toronto CF clinics were living in
Metropolitan Toronto.
Use of the database information for the analyses in this
study was approved by the institutional human ethics
committees.
Clinical characteristics
All clinical information was obtained from the patient CF
database. We assessed the clinical features at presentation
including age at diagnosis, nutritional status, pancreatic
function, and duration and severity of respiratory and
gastrointestinal symptoms prior to diagnosis. Symptoms
were considered to be severe if the patient required
hospitalisation or had a history of pneumonia, severe
functional impairment, or marked failure to thrive. Chronic
cough, repeated infections, poor growth, and other symptoms
leading to the CF diagnosis but not requiring hospitalisation
were defined as moderate symptoms. We also recorded the
most recent FEV1 and nutritional status. Z-scores for
height, weight, and body mass index (BMI) were computed
from the 2000 CDC growth charts.14 Nutritional status was
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characterised as the percentage of ideal body weight. Ideal
weight was computed as the weight corresponding to the
same z-score as the height z-score for that patient. We
analysed the clinical manifestations of the paediatric (,18
years) and adult (.18 years) CF patients separately.
Genotype analysis
Genomic DNA was screened by allele specific oligonucleotide
hybridisation. Extensive mutation analysis was then per-
formed on DNA from patients with undefined mutations
using PCR based multiplex heteroduplex analysis in an MDE
gel matrix, followed by direct DNA sequencing. This method
is estimated to identify up to 95% of all known CFTR gene
mutations.15 The poly-thymidine tract (5T, 7T, or 9T) in the
acceptor splice site of intron 8 was also characterised.
Statistical analysis
Fisher’s exact test was used to compare proportions for
categorical variables. Significance of difference in age at
diagnosis was assessed by the Mann-Whitney test. Student’s
t test was used to compare mean values for other continuous
variables.
Results are given as mean and SD or median and range, as
appropriate. Multiple regression analysis was used to adjust
for different age distribution in comparing FEV1 and
percentage of ideal weight between the two groups. A p
value of less than 0.05 was considered significant.
RESULTS
Prevalence
Between 1996 and 2001, 381 patients with CF were living in
the Metropolitan Toronto Area. Fifteen (3.9%) patients were
of South Asian descent, including 11 Indian, two Sri Lankan,
and two of Pakistani descent. According to Statistics Canada,
1996 Census, the population of Metropolitan Toronto was
4 232 905. The South Asian population of 329 840 accounted
for 7.8% of the total population.
The 1996 census data subdivided the population into
specific age groups. Therefore, we used the same age groups
to compare the age related prevalence of CF in the general
population and in the South Asian population. The age
specific prevalence of cystic fibrosis in the two groups is
shown in table 1. Overall CF was 28% less prevalent in South
Asians under 15 years of age, than in the general population
(1:9200 versus 1:6600, p=0.33). However, the difference in
prevalence between the two groups became more pronounced
at an older age, and in those older than 25 years the
difference in prevalence was highly significant (p , 0.001).
In order to minimise bias due to age differences,
subsequent comparisons of clinical features were limited to
patients aged 35 years or younger, excluding 57 older patients
in the general CF population.
Clinical features at diagnosis
As shown in table 2, the median age at diagnosis in the South
Asian population was not different from the general CF
population. Similarly, there was no significant difference in
the proportion of patients with prolonged respiratory or
gastrointestinal symptoms (.6 months) prior to diagnosis
between the two groups. The severity of respiratory and
gastrointestinal symptoms at diagnosis was also not different
in the groups. However, there was evidence of poorer weight
expressed as a percentage of ideal weight in the South Asian
patients, for the reduced sample with measurements within
one year of diagnosis (90¡14, n=11 versus 100¡14,
n=275, p=0.02). While pancreatic sufficiency (PS) was
more common in the South Asian CF population (27% versus
16%) the difference was not statistically significant. There
was no difference in the mean sweat chloride levels at
diagnosis. Seven PS patients (one South Asian) ranging in
age from 2 to 35 years had sweat chloride values below the
classic diagnostic cut-off of 60 mmol/l. The South Asian
patient was a 19 year old girl with the 3849+10kbCRT
mutation known to be associated with variable sweat
chloride. Her other mutation was unidentified, but her nasal
potential difference profile confirmed CF. The other six
patients all had two CF mutations identified. Two were
homozygous for rare mutations (1868A.G and D1152H) and
four were heterozygous for DF508 (R117H/7T(2), R117H/5T,
5T). The patients with R117H/7T, 5T, and homozygous
D1152H all had nasal potential difference testing which
confirmed CF.
Most recent clinical features
The mean age of the South Asian CF population was younger
than the general CF population (table 2). Children 0–4 years
represent 27% of all South Asian CF versus 7% in the general
CF population. Forty four per cent of the CF patients in the
general population were 25 years or older, whereas only two
South Asian patients (13%) were older than 25 years.
South Asian patients tended to weigh less and be shorter
but the differences were not significant. Weight, expressed as
a percentage of ideal weight for height was normal on
average in both groups (table 2). However, using percentage
of ideal weight of less than 90% as an indicator of
malnutrition, 27% of the general CF population and 33% of
the South Asians were malnourished. Regression analysis of
percentage of ideal weight versus age showed no age
dependent differences between the groups.
As shown in fig 1, mean FEV1 (% predicted for age and
sex) was similar in the two groups (64¡24% in South Asians
versus 67¡29% in the general CF population). Mean FEV1 in
the paediatric South Asian group (76¡17%) was very similar
to the general population of CF patients (78¡25%). However,
mean FEV1 tended to be lower in the adult South Asians
compared with the adult general CF population. Using
regression analysis to account for the age difference, FEV1
was found to be 7% lower in South Asians than in the general
population, but this difference was not significant (p=0.4).
Pseudomonas aeruginosa was isolated from 67% of the South
Asians and from 61% of the general CF population (p=0.6).
Eleven per cent of patients in the general CF population and
13% of the South Asians died during the five year study
period.
Table 1 Prevalence of CF among South Asians and the general population living in Metropolitan Toronto
Age (years)
South Asians General population
p valueCF Population Prevalence CF Population Prevalence
0–14 9 82921 1:9200 130 858155 1:6600 0.33
15–24 4 52858 1:13200 73 553370 1:7600 0.27
25–44* 2 113250 1:56600 ,0.001
25–54* 163 2021530 1:12400
*The difference in adult age groups reflects different adult age categories in Statistics Canada data for the general and South Asian populations. Since the oldest CF
patient of South Asian descent was 35, the difference in prevalence over age 25 is even greater than that presented in the table.
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Genetics
Extensive mutation analysis was performed in 301 (93%)
patients under age 36, including 13 South Asians (table 3).
CFTR gene mutations were identified on both alleles of 248
(86%) of the general population and eight (61.5%) South
Asian patients. Forty three per cent of the general population
and 46% of the South Asians were found to be homozygous
for DF508. However, the overall frequency of DF508 allele
was lower in South Asians (50% versus 65.1%) than in the
general CF population. Other mutations identified in the
South Asian population are listed in table 3. Extensive
mutation analysis failed to identify mutations in 26.9%
alleles in South Asians and in 8.2% of alleles in the general
CF population.
DISCUSSION
CF is considered to be rare among individuals of non-
European Caucasian origin, including those whose ethnicity
originates from the Indian subcontinent. Since the first
description of the existence of CF in a South Asian patient in
1968,3 several case series have attempted to define the
prevalence and clinical characteristics of CF in patients of this
ethnic origin. While prevalence estimates of CF in this ethnic
group are not clearly defined, several studies have suggested
that it is considerably lower than in Caucasians of European
origin. In a survey of 116 CF centres in the United States,
Powers and colleagues11 found only 20 patients of Asian
Indian descent. Based on the estimation of the Asian Indian
population in the 1990 US census report, an incidence of
1:40 750 was suggested. However, the authors speculated
that they may have greatly underestimated the real incidence
of CF in individuals from this ethnic group. Since all 20
patients in this survey were diagnosed during the last decade,
older patients with CF may have been missed. Goodchild and
colleagues8 identified three children with CF of Pakistani
origin in the West Midland region of England. A ques-
tionnaire, sent to all paediatricians in this area, failed to find
any other South Asians with CF. A population survey
estimated the South Asian population in this region to be
approximately 30 000, which suggested an incidence of
1:10 000. They hypothesised that most South Asians are
Caucasian by race, and therefore the incidence of CF in South
Asians might be even higher than their population based
estimation.
Curtis and colleagues12 calculated the incidence of CF
based on limited CFTR mutation analysis of DNA from
unrelated, unaffected Indians who donated blood in Bombay.
DF508 mutation was not detected in DNA from 400
individuals, while none of the exon 11 mutations G551D,
R553X, or S549 were identified in DNA from 200 of these
patients. Since very few mutations were screened and the
relative frequency of the common CFTR gene mutations in
the South Asians has not been determined, this report may
well have underestimated the incidence of CF carrier status
in this population.
While the US survey found only 20 patients of South Asian
descent in the whole US population (248 709 873),11 we
Table 2 Clinical manifestations of cystic fibrosis among South Asians and the general
population
Clinical manifestations
South Asian CF
patients (n = 15)
General CF patients
(n = 309) p value
Symptoms before diagnosis
Respiratory, .6 m % 33 32 0.9`
Gastrointestinal, .6 m % 13 30 0.2`
At diagnosis
Median age (range) 6 m (0–19 y) 7 m (0–35 y) 0.4*
Pancreatic sufficiency % 27 16 0.14
Moderate-severe respiratory
symptoms %
27 33 0.8`
Moderate-severe gastrointestinal
symptoms %
53 58 0.8`
Sweat chloride concentration
mmol/l, median (range)
95 (47–126) 101 (30–166) 0.2
At most recent visit
Age (years) 12.8¡10.1 18.4¡10.0 0.04
Height z-score 20.8¡0.9 20.4¡1.0 0.10
Weight z-score 20.9¡1.4 20.6¡1.3 0.3
BMI z-score 20.5¡1.3 20.5¡1.3 0.9
Weight, % of ideal 101¡20 99¡14 0.6
FEV1, % predicted 64¡24 67¡29 0.8
Pseudomonas aeruginosa, % 67 61 0.6`
*Mann-Whitney test.
Student’s t test.
`Fischer’s exact test.
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Figure 1 Pulmonary functions in individual CF patients of South Asian
origin compared with the general CF population showing FEV1 in CF
South Asian patients to be within the FEV1 range (mean ¡ SEE) for the
age related general CF population. SEE, standard error of estimate.
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identified 15 children of the same ethnic origin in a
population that was 50-fold smaller. In fact, the prevalence
of CF among young South Asians living in Metropolitan
Toronto was higher than all other previous estimates and
similar to that observed in the age matched general
population. A much lower prevalence of CF among South
Asian adults living in the same geographic region suggests
that South Asian patients born with CF two or more decades
ago either died or remain undiagnosed. This observation
leads us to speculate that previously there was inadequate
awareness of the existence of CF among individuals of South
Asian origin. Consequently, only the more severe cases may
have been diagnosed. This might explain the more severe
clinical course described in previous reports,8 11 and the
somewhat lower FEV1 in our adult South Asian CF
population. With larger numbers, some of the clinical
differences we explored may have been significant, but the
magnitude of difference is still much smaller than previously
reported.
In a recent series of 17 patients from North India the
mean duration of symptoms prior to diagnosis was 4.05¡
2.1 years, and mean age at diagnosis was 4.78¡3.42 years.5
It is noteworthy that three patients (18%) in that report
were diagnosed at postmortem examination. In contrast to
all published reports, we found no evidence of delayed
diagnosis of CF among our patients of South Asian origin.
Furthermore, age at diagnosis, duration of symptoms prior
to diagnosis, and severity of symptoms at diagnosis were
quite similar to the general CF population. Taken together,
this information suggests that physicians practicing in
our region now have appropriate awareness of the exist-
ence of this disease among children of South Asian origin.
Furthermore, with prompt diagnosis and therapy the
clinical course among CF children of South Asian origin is
no different to the general CF population. Socioeconomic
status may have an impact on access to medical services
among immigrant families. However, universal access
to medical care and specialised CF centres in Canada
would make this issue less likely in our study than in other
reports.
The most common mutation in the Caucasian CF popula-
tion, DF508, accounts for 66% of CF chromosomes on a
worldwide basis.16 Previous reports have suggested a lower
prevalence of DF508 in patients from the Indian subconti-
nent. A review of all genotyped South Asian patients,
reported in published articles6 7 9–12 and together with those
reported in the current series, shows that DF508 was
identified in 66 of 162 (41%) alleles, which appears to be
considerably lower than the reported frequency of 66% in the
worldwide CF population. Furthermore, extensive mutation
analysis failed to identify CFTR gene mutations in 26.9% of
the South Asian alleles in our study. We found several rare
mutations, all but one of which have been identified in
patients originating from the Indian subcontinent or neigh-
bouring regions. Nevertheless, DF508 remained the most
common CFTR gene mutation in this South Asian population
and the prevalence was only slightly less than that observed
in our general CF population. This observation supports the
hypothesis that immigration patterns between Europe and
the Indian subcontinent are contributing to the evolution of
CF in the Indian subcontinent.
The higher than expected frequency of PS patients and the
lower mutation detection among South Asians may reflect a
higher frequency of rare mild variants or intronic mutations
not specifically included in our current screening methods. In
addition, the protocol is less efficient in detecting homo-
zygotes for point mutations, so that if some of the SA patients
are homozygous for rare mutation(s) they could be unde-
tected.
In summary, we show for the first time that the prevalence
and clinical presentation of CF in the young South Asians are
similar to a general CF population residing in the same
geographic region. Our observations also provide indirect
evidence of an improvement in knowledge among physicians
of the existence of CF among individuals of South Asian origin.
Table 3 CFTR gene mutations among CF patients of South Asian origin and all patients living in the same geographic region in
the CF population
Mutation
South Asian CF population
Mutation
General CF population
(number, % of total alleles) (number, % of total alleles)
No. identified % of alleles No. identified % of alleles
DF508 13 50 DF508 375 65.1
L218X 2 7.7 W1282X 16 2.8
1525-1GRA 1 3.8 G551D 15 2.6
S549N 1 3.8 G542X 10 1.7
3849+10kbCRT 1 3.8 621+1GRT 10 1.7
V392G 1 3.8 R117H 7 1.2
N1303K 7 1.2
49 others (,1%) 89 16.4
Unidentified 7 26.9 Unidentified 47 8.2
What is already known on this topic
N CF is rare in populations not of European Caucasian
origin
N More severe disease has been reported in South Asian
CF patients
N DF508, the most common mutation in Caucasians, is
less prevalent in South Asians
What this study adds
N Prevalence and clinical course of CF in children of
South Asian origin is similar to that in the general
Toronto population
N Previous reports reflect inadequate awareness of CF in
this ethnic group
N The prevalence of DF508 is confirmed to be lower in
South Asians than other Caucasian groups
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